BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2045034)

  • 1. [Treatment of drug dependent patients with methadone. 1: Goals, types and results of methadone programs].
    Böcker FM
    Fortschr Med; 1991 Feb; 109(5):129-31. PubMed ID: 2045034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of drug-dependent patients with methadone. 2: AIDS prevention by drug substitution?].
    Böcker FM
    Fortschr Med; 1991 Feb; 109(5):132-5. PubMed ID: 2045035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retention in methadone maintenance drug treatment for prescription-type opioid primary users compared to heroin users.
    Banta-Green CJ; Maynard C; Koepsell TD; Wells EA; Donovan DM
    Addiction; 2009 May; 104(5):775-83. PubMed ID: 19344438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrating the methadone patient in the traditional addiction inpatient rehabilitation program--problems and solutions.
    Kipnis SS; Herron A; Perez J; Joseph H
    Mt Sinai J Med; 2001 Jan; 68(1):28-32. PubMed ID: 11135503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparing drug-related hospital morbidity following heroin dependence treatment with methadone maintenance or naltrexone implantation.
    Ngo HT; Tait RJ; Hulse GK
    Arch Gen Psychiatry; 2008 Apr; 65(4):457-65. PubMed ID: 18391134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Psychodynamic aspects of treatment of heroin dependent patients with methadone substitution].
    Scherbaum N; Heigl-Evers A
    Psychother Psychosom Med Psychol; 1996 Feb; 46(2):47-51. PubMed ID: 8851065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug use and HIV/AIDS in China.
    Liu Z; Lian Z; Zhao C
    Drug Alcohol Rev; 2006 Mar; 25(2):173-5. PubMed ID: 16627308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heroin prescription in Europe: heroin treatment is a pragmatic way of reducing the risks associated with addiction.
    Prescrire Int; 2003 Dec; 12(68):235-6. PubMed ID: 14986702
    [No Abstract]   [Full Text] [Related]  

  • 9. [Dutch research on the effectiveness of medical prescription of heroin; background, research design and preliminary results].
    van den Brink W; Hendriks VM; Blanken P; van Ree JM
    Ned Tijdschr Geneeskd; 2000 Jan; 144(3):108-12. PubMed ID: 10674115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Medical and psychosocial effects of methadone substitution in HIV infected substance-dependent patients].
    Walger P; Baumgart P; Wilke G; Kupfer U; von Eiff M; Dorst KG
    Psychother Psychosom Med Psychol; 1989 Nov; 39(11):381-9. PubMed ID: 2587688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous and intranasal heroin-dependent treatment-seekers: characteristics and treatment outcome.
    Highfield DA; Schwartz RP; Jaffe JH; O'Grady KE
    Addiction; 2007 Nov; 102(11):1816-23. PubMed ID: 17784892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Development of lymphocyte subpopulations (CD4, CD8) in levomethadone treated HIV infected intravenous drug dependent patients].
    Hofmeister-Wagner WD; Wiesner von Jagwitz E; Streidl C; Peters M
    Offentl Gesundheitswes; 1991; 53(8-9):457-8. PubMed ID: 1837872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Use of methadone in the treatment of narcotic addiction].
    Tiljak H
    Lijec Vjesn; 1998 May; 120(5):125-31. PubMed ID: 9748791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized controlled trial of interim methadone maintenance.
    Schwartz RP; Highfield DA; Jaffe JH; Brady JV; Butler CB; Rouse CO; Callaman JM; O'Grady KE; Battjes RJ
    Arch Gen Psychiatry; 2006 Jan; 63(1):102-9. PubMed ID: 16389204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methadone advocacy: the voice of the patient.
    Woods J
    Mt Sinai J Med; 2001 Jan; 68(1):75-8. PubMed ID: 11135509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multimodal drug addiction treatment: a field comparison of methadone and buprenorphine among heroin- and cocaine-dependent patients.
    Vigezzi P; Guglielmino L; Marzorati P; Silenzio R; De Chiara M; Corrado F; Cocchi L; Cozzolino E
    J Subst Abuse Treat; 2006 Jul; 31(1):3-7. PubMed ID: 16814005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality of life among heroin users on buprenorphine versus methadone maintenance.
    Ponizovsky AM; Grinshpoon A
    Am J Drug Alcohol Abuse; 2007; 33(5):631-42. PubMed ID: 17891656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychoeducational group approach: HIV risk reduction in drug users.
    Sorensen JL; London J; Heitzmann C; Gibson DR; Morales ES; Dumontet R; Acree M
    AIDS Educ Prev; 1994 Apr; 6(2):95-112. PubMed ID: 8018443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benefits of retention in methadone maintenance and chronic medical conditions as risk factors for premature death among older heroin addicts.
    Fareed A; Casarella J; Amar R; Vayalapalli S; Drexler K
    J Psychiatr Pract; 2009 May; 15(3):227-34. PubMed ID: 19461397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluating the impact of methadone maintenance programmes on mortality due to overdose and aids in a cohort of heroin users in Spain.
    Brugal MT; Domingo-Salvany A; Puig R; Barrio G; García de Olalla P; de la Fuente L
    Addiction; 2005 Jul; 100(7):981-9. PubMed ID: 15955014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.